Use of Tacrolimus for the Treatment of Pediatric Noninfectious Uveitis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Systemic tacrolimus shows promise for treating pediatric noninfectious uveitis refractory to standard treatments. This calcineurin inhibitor was found to be a safe and effective option in a small cohort of young patients.
Area Of Science
- Ophthalmology
- Immunology
- Pediatric Medicine
Background
- Pediatric noninfectious uveitis often presents treatment challenges.
- Limited therapeutic options exist for refractory pediatric cases.
Purpose Of The Study
- To investigate the efficacy and safety of systemic tacrolimus in children with noninfectious uveitis.
- To evaluate tacrolimus as an adjuvant immunomodulatory treatment for pediatric refractory uveitis.
Main Methods
- Retrospective chart review of 11 pediatric patients (≤18 years) with refractory noninfectious uveitis.
- Analysis of treatment success defined by ocular inflammation markers and topical steroid use at 6 and 12 months.
- Assessment of adverse events and need for treatment discontinuation.
Main Results
- Treatment success was achieved in 88.9% at 6 months and 63.6% at 12 months.
- Seven patients experienced laboratory abnormalities, but tacrolimus was not discontinued.
- Therapeutic tacrolimus levels were achieved with a mean dose of 0.16 mg/kg/day.
Conclusions
- Systemic tacrolimus appears to be a well-tolerated and effective treatment for refractory pediatric noninfectious uveitis.
- Tacrolimus offers a potentially safe therapeutic option for this challenging patient population.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...